Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 183

The DOI matches its Crossref record.

Children's Oncology Group's 2013 blueprint for research: Renal tumors

Open access
Dome, Jeffrey S., Fernandez, Conrad V., Mullen, Elizabeth A., Kalapurakal, John A., Geller, James I., Huff, Vicki, Gratias, Eric J., Dix, David B., Ehrlich, Peter F., Khanna, Geetika, Malogolowkin, Marcio H., Anderson, James R., Naranjo, Arlene, Perlman, Elizabeth J., on behalf of the COG Renal Tumors Committee·2013·Pediatric Blood & Cancer

Abstract

Renal malignancies are among the most prevalent pediatric cancers. The most common is favorable histology Wilms tumor (FHWT), which has 5‐year overall survival exceeding 90%. Other pediatric renal malignancies, including anaplastic Wilms tumor, clear cell sarcoma, malignant rhabdoid tumor, and renal cell carcinoma, have less favorable outcomes. Recent clinical trials have identified gain of chromosome 1q as a prognostic marker for FHWT. Upcoming studies will evaluate therapy adjustments based on this and other novel biomarkers. For high‐risk renal tumors, new treatment regimens will incorporate biological therapies. A research blueprint, viewed from the perspective of the Children's Oncology Group, is presented. Pediatr Blood Cancer 2013; 60: 994–1000. © 2012 Wiley Periodicals, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/pbc.24419

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 183

Metadata

Authors
Dome, J. S., Fernandez, C. V., Mullen, E. A., Kalapurakal, J. A., Geller, J. I., Huff, V., Gratias, E. J., Dix, D. B., Ehrlich, P. F., Khanna, G., Malogolowkin, M. H., Anderson, J. R., Naranjo, A., Perlman, E. J., & on behalf of the COG Renal Tumors Committee
Venue
Pediatric Blood & Cancer
Publisher
Wiley
Published
2012-12-19
Volume
60
Issue
6
Pages
994-1000
ISSN
  • 1545-5009 (ISSN-L)
  • 1545-5017
OpenAlex
W1989901777
Cited by
183
References
0
FWCI
3.14
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Children's Oncology Group's 2013 blueprint for research: Renal tumors. https://app.cochat.ai/papers/10.1002/pbc.24419
The paper
Dome, J. S., Fernandez, C. V., Mullen, E. A., Kalapurakal, J. A., Geller, J. I., Huff, V., Gratias, E. J., Dix, D. B., Ehrlich, P. F., Khanna, G., Malogolowkin, M. H., Anderson, J. R., Naranjo, A., Perlman, E. J., & on behalf of the COG Renal Tumors Committee. (2013). Children's Oncology Group's 2013 blueprint for research: Renal tumors. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.24419

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.